Clinical Trial Highlights

• FFR- and Angiography-Guided Provisional Side Branch Stenting Offer Similar Benefits
• Lower 30-Day Mortality after Early Stent Thrombosis with Bivalirudin vs Heparin
• Shorter Clopidogrel Therapy Not Superior following Coronary DES Implantation
• TAVR Suitable Procedure for High-Risk AS Patients: 5-Year Results from the PARTNER Trial
• ABSORB II: Comparable Clinical Outcomes Noted with ABSORB Scaffold and XIENCE Stents
• CLEAN-TAVI: Less Radiological Evidence of Stroke in Patients Treated with TAVR Plus a Cerebral Embolic Filter
• RIBS IV: EES Superior to Paclitaxel-Eluting Balloon for Treating DES Restenosis
• Low 2-Year All-Cause Mortality and Major Stroke Rates after CoreValve Implantation
• Bivalirudin More Beneficial than Heparin in Patients with AMI Undergoing PCI: The BRIGHT Trial
• Six-Month DAPT Noninferior to 12-Month Regimen following Stent Implantation
• RSD Effective in Some Patients with Mildly Elevated BP
• VELOCITY: Pre-PCI Hypothermia Increases Adverse Event Rate without Reducing Infarct Size
• ELA Useful in Treatment of Femoropopliteal ISR
• Satisfactory Angiographic and Clinical Outcomes with the Everolimus-Eluting BVS
• Similar 12-Month BP Reductions with Renal Denervation and Sham Procedure
• Lead Shield and Protective Cap Reduce Operator Radiation Exposure by >75%
• Cangrelor Reduced Ischemic Event Risk, Even with Restrictive MI and ST Definitions